VISITECT CD4半定量测试用于晚期HIV疾病筛查的诊断性能和可用性

VISITECT CD4测试在非洲三地用于晚期HIV筛查的诊断性能(敏感性95-98%,特异性77-82%)及可用性评估数据集。

NIAID Data Ecosystem
浏览 13
表格reference test methodNsanje district hospitalVisitect CD 4 Lateral Flow AssayDRCVisitect CD 4 LFAAHD200 CD 4cells 3PHCconduct Visitect CD 4 LFA testingindex testCD 4 screeningFP
Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening

基本信息

模态
表格
大小
0.006650468 GB
许可
CC BY 4.0
创建/更新时间
2026-10-07
版本
v1

资源简介

VISITECT CD4半定量测试用于晚期HIV疾病筛查的诊断性能和可用性

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 2 个文件、合计 6.65 MB,主题涵盖 reference test method、Nsanje district hospital、Visitect CD 4 Lateral Flow Assay、DRC、Visitect CD 4 LFA,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening》。配套论文《Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening》发表于 PLOS ONE(2020),DOI:10.1371/journal.pone.0230453。源站首次发布:2020-04-03。

【数据内容】

源站原始描述:Background In sub-Saharan Africa, a third of people starting antiretroviral therapy and majority of patients returning to HIV-care after disengagement, present with advanced HIV disease (ADH), and are at high risk of mortality. Simplified and more affordable point-of-care (POC) diagnostics are required to increase access to prompt CD4 cell count screening for ambulatory and asymptomatic patients. The Visitect CD4 Lateral Flow Assay (LFA) is a disposable POC test, providing a visually interpreted…

【数据结构与技术规格】

文件数 2 个,合计 6.65 MB。pone.0230453.s002.tif:image/tiff,1.01 MB。数据集 DOI:10.1371/journal.pone.0230453。

【主题与分类】

源站学科分类:Medicine、Cell Biology、Infectious Diseases。主题标签:reference test method、Nsanje district hospital、Visitect CD 4 Lateral Flow Assay、DRC、Visitect CD 4 LFA、AHD、200 CD 4cells 3、PHC、conduct Visitect CD 4 LFA testing、index test。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Diagnostic_performance_and_usability_of_the_VISITECT_CD4_semi-quantitative_test_for_advanced_HIV_disease_screening/12079464

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Ndlovu, Zibusiso; Massaquoi, Lamin; Bangwen, Ndim Eugene; Batumba, John N.; Bora, Rachelle U.; Mbuaya, Joelle; et al. (2020). Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-01,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "pone.0230453.s001.tif" "https://ndownloader.figshare.com/files/22207068"
curl -L -o "pone.0230453.s002.tif" "https://ndownloader.figshare.com/files/22207074"

文件清单

  • pone.0230453.s001.tif(5.64 MB)
  • pone.0230453.s002.tif(1.01 MB)

文件总体积 6.65 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
In sub-Saharan Africa, a third of people starting antiretroviral therapy and majority of patients returning to HIV-care after disengagement, present with advanced HIV disease (ADH), and are at high risk of mortality. Simplified and more affordable point-of-care (POC) diagnostics are required to increase access to prompt CD4 cell count screening for ambulatory and asymptomatic patients. The Visitect CD4 Lateral Flow Assay (LFA) is a disposable POC test, providing a visually interpreted result of above or below 200 CD4cells/mm3. This study evaluated the diagnostic performance of this index test.
Methods
Consenting patients above 18years of age and eligible for CD4 testing were enrolled in Nsanje district hospital (Malawi), Gutu mission hospital (Zimbabwe) and Centre hopitalier de Kabinda (DRC). A total of 708 venous blood samples were tested in the index test and in the BD FACSCount assay (reference test method) in the laboratories (Phase 1) to determine diagnostic accuracy. A total of 433 finger-prick (FP) samples were tested on the index test at POC by clinicians (Phase 2) and a self-completed questionnaire was administered to all testers to explore usability of the index test.
Results
Among 708 patients, 67.2% were female and median CD4 was 297cells/mm3. The sensitivity of the Visitect CD4 LFA using venous blood in the laboratory was 95.0% [95% CI: 91.3–97.5] and specificity was 81.9% [95% CI: 78.2–85.2%]. Using FP samples, the sensitivity of the Visitect CD4 LFA was 98.3% [95% CI: 95.0–99.6] and specificity was 77.2% [95% CI: 71.6–82.2%]. Usability of the Visitect CD4 LFA was high across the study sites with 97% successfully completed tests. Due to the required specific multiple incubation and procedural steps during the Visitect CD4 LFA testing, few health workers (7/26) were not confident to manage testing whilst multi-tasking in their clinical work.
Conclusions
Visitect CD4 LFA is a promising test for decentralized CD4 screening in resource-limited settings, without access to CD4 testing and and it can trigger prompt management of patients with AHD. Lay health cadres should be considered to conduct Visitect CD4 LFA testing in PHCs as well as coor

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0230453(source: https://plos.figshare.com/articles/dataset/Diagnostic_performance_and_usability_of_the_VISITECT_CD4_semi-quantitative_test_for_advanced_HIV_disease_screening/12079464)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案